Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Heptex in Patients with Risk Factors of NASH
NCT05343780Phase 2Completed
- Sponsor
- Natural Wellness
- Start
- May 2019
- Primary completion
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Heptex in Nonalcoholic steatohepatitis (NASH), sponsored by Natural Wellness. Started May 2019; status: completed.
02
Drugs
Heptex
03
Conditions
Nonalcoholic steatohepatitis (NASH)
Beyond the preview
Go deeper on NCT05343780.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05343780.